Immunic Inc.

NASDAQ: IMUX · Real-Time Price · USD
0.90
-0.02 (-1.80%)
At close: Aug 15, 2025, 3:59 PM
0.91
1.27%
After-hours: Aug 15, 2025, 07:58 PM EDT

Immunic Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
55.31M 14.3M 35.67M 59.07M 79.7M 97.31M 46.67M 59.69M 77.29M 92.76M 106.75M 72.77M 88.08M 95.71M 86.86M 110.44M 87.17M 114.84M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.35M 9.63M n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a 43K 43K 43K 43K 42K 42K 42K 42K 42K 42K 42K
Receivables
594K 631K 684K 780K 806K 770K 703K 1.19M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a 2.3M 3.81M -3.67M 5.61M 8.94M -3.27M 15.41M -2.15M 7.87M 6.61M 2.56M
Other Current Assets
3.94M 2.34M 1.11M 796K 696K 1.77M 2.84M -250K 4.06M 3.67M 3.88M 3.39M 3.27M 3.21M 2.15M 2.9M 6.41M 2M
Total Current Assets
59.84M 18.98M 39.33M 63.27M 84.98M 102.61M 52.53M 65.23M 86.55M 106.58M 125.86M 86.65M 104.76M 115.88M 104.99M 122.5M 101.69M 120.28M
Property-Plant & Equipment
1.59M 1.54M 1.54M 1.5M 1.51M 1.54M 1.76M 1.7M 2.15M 2.25M 1.85M 1.42M 884K 1.03M 1.1M 1.25M 1.36M 1.43M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 32.97M 32.97M 32.97M 32.97M 32.97M 32.97M 32.97M
Total Long-Term Assets
1.59M 1.54M 1.54M 1.5M 1.51M 1.54M 1.76M 1.74M 2.19M 2.29M 1.89M 34.43M 33.9M 34.04M 34.11M 34.26M 34.37M 34.44M
Total Assets
61.43M 20.52M 40.87M 64.76M 86.49M 104.16M 54.3M 66.98M 88.74M 108.87M 127.75M 121.08M 138.66M 149.92M 139.1M 156.76M 136.06M 154.72M
Account Payables
7.89M 5.51M 7.56M 5.79M 7.89M 6.77M 5.1M 3.2M 4.7M 5.24M 4.28M 4.17M 4.12M 3.29M 3.75M 3.24M 4.18M 10.05M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a 12.96M n/a n/a n/a 5.38M n/a 6.66M 7.14M 10.13M 14.6M
Short-Term Debt
774K 765K 740K 713K 714K 697K 695K 662K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
16.41M 541K 290K 15.89M 12.36M 11.38M 16.78M -401K 257K 10.08M 7.33M 6.07M 5.31M 7.45M 6.57M 173K 6.06M 93K
Total Current Liabilities
27.31M 25.59M 22.18M 23.36M 22.68M 20.15M 24.73M 17.78M 18.24M 16.3M 13.08M 11.51M 10.4M 11.46M 11.4M 10.59M 14.49M 16.36M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
205K 210K 264K 186K 241K 433K 639K 789K 1.21M 1.35M 992K 759K 407K 502K 584K 701K 829K 922K
Total Liabilities
27.52M 25.8M 22.44M 23.54M 22.92M 20.58M 25.37M 18.57M 19.45M 17.65M 14.07M 12.27M 10.81M 11.96M 11.98M 11.29M 15.32M 17.28M
Total Debt
979K 975K 1M 899K 955K 1.13M 1.33M 1.45M 1.89M 1.35M 1.56M 1.15M 407K 906K 584K 1.11M 1.02M 1.31M
Common Stock
9K 8K 8K 8K 8K 8K 4K 4K 4K 4K 4K 3K 3K 3K 3K 3K 2K 2K
Retained Earnings
-563.69M -536.87M -511.4M -486.22M -461.86M -440.48M -410.89M -389.32M -366.55M -342.55M -317.28M -260.81M -239.58M -217.68M -196.87M -175.69M -156.4M -138.46M
Comprehensive Income
2.52M 3.92M 4.21M 3.89M 3.78M 4.29M 3.76M 3.9M 3.98M 3.81M 3.04M -386K -660K -310K -252K -800K -1.4M -1.12M
Shareholders Equity
33.91M -5.29M 18.43M 41.22M 63.57M 83.58M 28.93M 48.41M 69.28M 91.22M 113.68M 108.81M 127.85M 137.96M 127.11M 145.47M 120.74M 137.45M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.35M 9.63M n/a n/a n/a n/a n/a n/a n/a